BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3816232)

  • 1. Severe pain at interval IUD insertion: a case-control analysis of patient risk factors.
    Chi IC; Galich LF; Tauber PF; Wilkens LR; Waszak CS; Siemens AJ; Lippes J
    Contraception; 1986 Nov; 34(5):483-95. PubMed ID: 3816232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do insertion-related problems affect subsequent IUD performance?
    Chi IC; Waszak CS; Wilkens LR
    Contraception; 1986 Nov; 34(5):497-503. PubMed ID: 3816233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between intrauterine contraceptive device use and breast-feeding status at time of intrauterine contraceptive device insertion: analysis of TCu-380A acceptors in developing countries.
    Farr G; Rivera R
    Am J Obstet Gynecol; 1992 Jul; 167(1):144-51. PubMed ID: 1442918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of endometriosis in women attending family planning clinics.
    Vessey MP; Villard-Mackintosh L; Painter R
    BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lactation and contraceptive use on birth-spacing in Bolivia.
    Forste R
    Soc Biol; 1995; 42(1-2):108-23. PubMed ID: 7481914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A national study to monitor the safety of IUCD use.
    Richardson A; Paul C
    Contraception; 1993 Apr; 47(4):359-66. PubMed ID: 8508665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive cervical cancer and intrauterine device use.
    Lassise DL; Savitz DA; Hamman RF; Barón AE; Brinton LA; Levines RS
    Int J Epidemiol; 1991 Dec; 20(4):865-70. PubMed ID: 1800424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic changes induced by insertion of an intrauterine device and other uterine manipulations.
    Aznar R; Reynoso L; Ley E; Gámez R; De León MD
    Fertil Steril; 1976 Jan; 27(1):92-6. PubMed ID: 1245249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast-feeding: patterns and correlates in Nepal.
    Tuladhar JM
    Asia Pac Popul J; 1990 Mar; 5(1):157-63. PubMed ID: 12283345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrauterine contraception in nulliparous women].
    Prilepskaia VN; Mezhevitinova EA
    Akush Ginekol (Mosk); 1991 Apr; (4):5-8. PubMed ID: 1862876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine device developments.
    Netw Res Triangle Park N C; 1984; 5(4):4-6. PubMed ID: 12313225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic inflammatory disease and the intrauterine contraceptive device.
    Wright EA; Aisien AO
    Int J Gynaecol Obstet; 1989 Feb; 28(2):133-6. PubMed ID: 2563699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine devices and pelvic inflammatory disease: an international perspective.
    Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O
    Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Success Providing Postpartum Intrauterine Devices in Private-Sector Health Care Facilities in Nigeria: Factors Associated With Uptake.
    Eluwa GIe; Atamewalen R; Odogwu K; Ahonsi B
    Glob Health Sci Pract; 2016 Jun; 4(2):276-83. PubMed ID: 27353620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.